|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 December 2000, Vol. 96, No. 13, pp. 4178-4184
HEMATOPOIESIS
Zebrafish homolog of the leukemia gene CBFB: its
expression during embryogenesis and its relationship to scl
and gata-1 in hematopoiesis
Trevor Blake,
Neeraj Adya,
Cheol-Hee Kim,
Andrew C. Oates,
Leonard Zon,
Ajay Chitnis,
Brant M. Weinstein, and
P. Paul Liu
From the National Human Genome Research Institute,
National Institutes of Health, Bethesda, MD; Howard Hughes Medical
Institute, Children's Hospital, Boston, MA; and National Institute of
Child Health and Human Development, National Institutes of Health,
Bethesda, MD.
Mammalian CBFB encodes a transcription factor (CBF )
that in combination with CBF 2 binds to specific DNA sequences and
regulates expression of a number of hematopoietic genes.
CBFB is associated with human leukemias through a
chromosome 16 inversion and is essential for definitive hematopoiesis
during mouse embryo development. We have isolated a zebrafish
cbfb complementary DNA (cDNA) clone from a zebrafish kidney cDNA
library. This cbfb is highly homologous to human and mouse
CBFB/Cbfb genes at both the DNA and protein level. In
biochemical analyses, cbf binds to human CBF 2 and enhances its
DNA binding. During zebrafish development, cbfb is expressed in the lateral plate mesoderm at tail bud stage and in the
intermediate cell mass (ICM, the location of embryonic hematopoiesis)
between the 21- to 26-somite stages. The cbfb is also
expressed in Rohon-Beard cells, cranial nerve ganglia, hindbrain, retina, branchial arches, jaw, and fin buds. Expression of
cbfb is decreased or absent in the ICM and
Rohon-Beard cells in some hematopoietic mutants and is unaffected in
others. We have also analyzed the expression of scl and
gata-1 in the same hematopoietic mutants to ascertain the
relative order of these transcription factors to cbfb in
zebrafish hematopoiesis. Our results indicate that cbfb is
expressed in early hematopoietic progenitors and that its expression
pattern in the hematopoietic mutants is similar to that of
scl.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H.-T. Huang and L.I. Zon
Regulation of Stem Cells in the Zebra Fish Hematopoietic System
Cold Spring Harb Symp Quant Biol,
November 6, 2008;
(2008)
sqb.2008.73.029v1.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hata, R. Nishimura, M. Ueda, F. Ikeda, T. Matsubara, F. Ichida, K. Hisada, T. Nokubi, A. Yamaguchi, and T. Yoneda
A CCAAT/Enhancer Binding Protein {beta} Isoform, Liver-Enriched Inhibitory Protein, Regulates Commitment of Osteoblasts and Adipocytes
Mol. Cell. Biol.,
March 1, 2005;
25(5):
1971 - 1979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Kalev-Zylinska, J. A. Horsfield, M. V. C. Flores, J. H. Postlethwait, M. R. Vitas, A. M. Baas, P. S. Crosier, and K. E. Crosier
Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis
Development,
March 6, 2003;
129(8):
2015 - 2030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Spitsbergen and M. L. Kent
The State of the Art of the Zebrafish Model for Toxicology and Toxicologic Pathology Research--Advantages and Current Limitations
Toxicol Pathol,
January 1, 2003;
31(1_suppl):
62 - 87.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Lyons, N. D. Lawson, L. Lei, P. E. Bennett, B. M. Weinstein, and P. P. Liu
A nonsense mutation in zebrafish gata1 causes the bloodless phenotype in vlad tepes
PNAS,
April 16, 2002;
99(8):
5454 - 5459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Bennett, J. P. Kanki, J. Rhodes, T. X. Liu, B. H. Paw, M. W. Kieran, D. M. Langenau, A. Delahaye-Brown, L. I. Zon, M. D. Fleming, et al.
Myelopoiesis in the zebrafish, Danio rerio
Blood,
August 1, 2001;
98(3):
643 - 651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Lyons, B. C. Shue, A. C. Oates, L. I. Zon, and P. P. Liu
A novel myeloid-restricted zebrafish CCAAT/enhancer-binding protein with a potent transcriptional activation domain
Blood,
May 1, 2001;
97(9):
2611 - 2617.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|